Yao Peng, Ren Bingkai, Zhou Qianhui, Bai Yang, Feng Zhen
Affiliated Rehabilitation Hospital, Jiang Xi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Rehabilitation Medicine Clinical Research Center of Jiangxi Province, Nanchang, Jiangxi, China.
CNS Neurosci Ther. 2025 Sep;31(9):e70606. doi: 10.1111/cns.70606.
Traumatic brain injury (TBI), a prevalent neurological disorder worldwide, is marked by varying degrees of neurological dysfunction. A key contributor to secondary damage and impediments in the repair process is the unregulated activation of microglia, which triggers neuroinflammation. Emerging evidence highlights the therapeutic potential of transcranial pulsed current stimulation (tPCS) in mitigating neurological deficits. However, despite these promising neuroprotective effects, its role and exact mechanisms in TBI remain unclear.
Herein, a mouse model of TBI was established, and daily 30-min tPCS treatments were administered for five consecutive days. Subsequently, we conducted comprehensive assessments of neurological function, microglial activation status, and neuroplasticity in the treated subjects. Additionally, a co-culture system of BV2 and HT22 cells was developed, using LPS to activate microglia, to explore potential neuroprotective mechanisms.
Our findings revealed that tPCS plays a crucial role in mitigating neuroinflammation and promoting neurological recovery following TBI. The underlying mechanism likely involves tPCS enhancing orexin-A (OX-A) expression, which subsequently suppresses the NF-κB pathway and promotes the expression of neurorepair-related markers. In vitro experiments further clarified these findings, demonstrating that OX-A effectively inhibited LPS-induced M1 microglial polarization and promoted a shift towards the M2 phenotype. Furthermore, OX-A significantly reduced intracellular ROS production and microglia-induced neuronal apoptosis.
These findings indicate that tPCS regulates microglial phenotype via the OX-A/NF-κB pathway, thereby suppressing neuroinflammation and enhancing neuroplasticity. These results provide a new perspective for the rehabilitation of individuals with TBI.
创伤性脑损伤(TBI)是一种在全球范围内普遍存在的神经疾病,其特征是不同程度的神经功能障碍。小胶质细胞的失控激活是继发性损伤和修复过程中障碍的一个关键因素,它会引发神经炎症。新出现的证据凸显了经颅脉冲电流刺激(tPCS)在减轻神经功能缺损方面的治疗潜力。然而,尽管有这些有前景的神经保护作用,其在TBI中的作用和确切机制仍不清楚。
在此,建立了TBI小鼠模型,并连续五天每天进行30分钟的tPCS治疗。随后,我们对治疗对象的神经功能、小胶质细胞激活状态和神经可塑性进行了全面评估。此外,利用脂多糖(LPS)激活小胶质细胞,建立了BV2和HT22细胞的共培养系统,以探索潜在的神经保护机制。
我们的研究结果表明,tPCS在减轻TBI后的神经炎症和促进神经恢复方面发挥着关键作用。潜在机制可能涉及tPCS增强食欲素-A(OX-A)的表达,进而抑制核因子-κB(NF-κB)途径,并促进神经修复相关标志物的表达。体外实验进一步阐明了这些发现,表明OX-A有效抑制LPS诱导的M1小胶质细胞极化,并促进向M2表型的转变。此外,OX-A显著降低细胞内活性氧(ROS)的产生以及小胶质细胞诱导的神经元凋亡。
这些发现表明,tPCS通过OX-A/NF-κB途径调节小胶质细胞表型,从而抑制神经炎症并增强神经可塑性。这些结果为TBI患者的康复提供了新的视角。